R.a. Session II, 10% Owner at Taysha Gene Therapies, Inc. (TSHA), sold 166,400 shares at $0.71 ($118K) on 2023-07-12, disclosed to the SEC on 2023-07-14.
Open-market sale of $118k TSHA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.71 | 80,528 | $57K | 48.4% |
| 2 | $0.71 | 80,528 | $57K | 48.4% |
| 3 | $0.70 | 5,344 | $4K | 3.2% |
| Total | $0.71 avg | 166,400 | $118K | 100% |
| Filing → |
| TSHA | BUY | 2021-12-08 | $1.1M | — | Filing → |